NCT03354702 is a NA clinical trial of Aerobic in Gambling Disorder, sponsored by University of Sao Paulo.

Who is sponsoring NCT03354702?

NCT03354702 is sponsored by University of Sao Paulo.

What drugs are being tested in NCT03354702?

Interventions in NCT03354702: Aerobic, Stretching.

What condition does NCT03354702 study?

NCT03354702 studies Gambling Disorder.

Is NCT03354702 still recruiting?

NCT03354702 is currently completed. Last updated 17 November 2020.

Last reviewed 2020-11-17 · How we verify

NCT03354702

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Physical Activity Pathological Gamblers

Completed NA Last updated 17 November 2020

What this trial tests

NA trial testing Aerobic in Gambling Disorder in 24 participants. Completed in 20 May 2018.

Timeline

12 March 2017

Primary endpoint
28 February 2018

20 May 2018

Quick facts

Lead sponsor	University of Sao Paulo
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	24
Start date	12 March 2017
Primary completion	28 February 2018
Estimated completion	20 May 2018
Sites	1 location across Brazil

Drugs / interventions tested

Aerobic
Stretching

Conditions studied

Gambling Disorder — all drugs for Gambling Disorder →

Sponsor

University of Sao Paulo

Who can join

Adults 18 to 75, any sex, with Gambling Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Gambling Disorder (GD) is defined as the recurrent and persistent act of betting which leads to clinical impairments,. The latest edition of the Diagnostic and Statistical Manual of Mental Disorders (5th edition) conceptualizes GD as a behavioral addiction due to the similarities between GD and substance addictions in clinical presentation, association with personality factors, genetic transmission and treatment options. Previous studies found potential benefits of physical activity in treatment of addictions in general and GD in particular, such as reducing desire to play, betting and depressive and anxious symptoms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Aerobic

Trials testing the same drug.

NCT06080542 — Influence of Aerobic Exercise and HIIT on Glycemic Control in Adult Men With Type 1 Diabetes (TAILOR/1b) · NA · completed
NCT03050606 — Effectiveness and Cost-effectiveness of Modified Pilates Method Versus Aerobic Exercise in Patients With Fibromyalgia · NA · unknown
NCT00321659 — Optimizing Fibromyalgia Self-management · NA · completed

Other recruiting trials for Gambling Disorder

Currently open trials in the same condition.

NCT03669315 — Modulating Inhibitory Control Networks in Gambling Disorder With Theta Burst Stimulation · Phase 3 · recruiting

Other University of Sao Paulo trials

Trials by the same sponsor.

NCT07463859 — Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabet · NA · recruiting
NCT07522554 — Lavender and Lemongrass Aromatherapy for Pain and Anxiety in Labor: A Randomized Trial · NA · active not recruiting
NCT07479940 — Obesity and Aging: Impacts of Nutritional Counseling and Physical Exercise on Telomeres and Senescence Parameters · NA · active not recruiting
NCT07445178 — Piecemeal Resection and Advanced Histology Independently Predict Local Recurrence After Colorectal Snare-based Endoscopi · completed
NCT07170007 — Physiotherapeutic Protocol Compared to Usual Care in the Treatment of Primiparas After Perineal Trauma · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03354702 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Sao Paulo
Last refreshed: 17 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03354702.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing